Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

National Institute for Occupational Safety and Health Nanomaterials and Worker Health Conference--medical surveillance session summary report.

Fischman M, Storey E, McCunney RJ, Kosnett M.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S35-7. doi: 10.1097/JOM.0b013e31821b1b0a.

PMID:
21606850
2.

Nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research.

Schulte PA, Trout DB.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S3-7. doi: 10.1097/JOM.0b013e31821b1b28.

PMID:
21654413
3.

Systematic Review of Screening and Surveillance Programs to Protect Workers from Nanomaterials.

Gulumian M, Verbeek J, Andraos C, Sanabria N, de Jager P.

PLoS One. 2016 Nov 9;11(11):e0166071. doi: 10.1371/journal.pone.0166071. eCollection 2016. Review.

4.

General principles of medical surveillance: implications for workers potentially exposed to nanomaterials.

Trout DB.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S22-4. doi: 10.1097/JOM.0b013e31821b1e45. Review.

5.

Nanomaterial risk assessment and management experiences related to worker health under the Toxic Substances Control Act.

Sayre P, Prothero S, Alwood J.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S98-102. doi: 10.1097/JOM.0b013e31821b1bdd.

PMID:
21654427
6.

Current surveillance plan for persons handling nanomaterials in the National University of Singapore.

Sng J, Quee DK, Yu LE, Gunaratnam S.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S25-7. doi: 10.1097/JOM.0b013e31821ad5dc.

PMID:
21654411
7.

Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace.

Boutou-Kempf O, Marchand JL, Radauceanu A, Witschger O, Imbernon E; Group Health Risks of Nanotechnologies.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S103-7. doi: 10.1097/JOM.0b013e31821b1d68.

PMID:
21654409
8.

The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.

Engeman CD, Baumgartner L, Carr BM, Fish AM, Meyerhofer JD, Satterfield TA, Holden PA, Harthorn BH.

J Occup Environ Hyg. 2013;10(9):487-95. doi: 10.1080/15459624.2013.818231.

PMID:
23927041
9.

Health and safety implications of occupational exposure to engineered nanomaterials.

Stebounova LV, Morgan H, Grassian VH, Brenner S.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 May-Jun;4(3):310-21. doi: 10.1002/wnan.174. Epub 2011 Nov 30. Review.

PMID:
22131295
10.

Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials.

Trout DB, Schulte PA.

Toxicology. 2010 Mar 10;269(2-3):128-35. doi: 10.1016/j.tox.2009.12.006. Epub 2009 Dec 16.

PMID:
20006668
11.

A small business approach to nanomaterial environment, health, and safety.

Gause CB, Layman RM, Small AC.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S28-31. doi: 10.1097/JOM.0b013e31821ad5f1.

PMID:
21654412
13.

Engineered nanomaterials: learning from the past, planning for the future.

Kreider T, Halperin W.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S108-12. doi: 10.1097/JOM.0b013e31821b146a.

PMID:
21654410
14.

Introduction to the JOEM Supplement nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research.

Schulte PA, Trout DB, Hodson LL.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S1-2. doi: 10.1097/JOM.0b013e31821aec09. No abstract available.

PMID:
21654408
15.

Options for occupational health surveillance of workers potentially exposed to engineered nanoparticles: state of the science.

Schulte PA, Trout D, Zumwalde RD, Kuempel E, Geraci CL, Castranova V, Mundt DJ, Mundt KA, Halperin WE.

J Occup Environ Med. 2008 May;50(5):517-26. doi: 10.1097/JOM.0b013e31816515f7. Review.

PMID:
18469620
16.

Handling worker and third-party exposures to nanotherapeutics during clinical trials.

Ramachandran G, Howard J, Maynard A, Philbert M.

J Law Med Ethics. 2012 Winter;40(4):856-64. doi: 10.1111/j.1748-720X.2012.00714.x.

PMID:
23289688
17.

Sharpening the focus on occupational safety and health in nanotechnology.

Schulte P, Geraci C, Zumwalde R, Hoover M, Castranova V, Kuempel E, Murashov V, Vainio H, Savolainen K.

Scand J Work Environ Health. 2008 Dec;34(6):471-8.

18.

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

Warheit DB, Borm PJ, Hennes C, Lademann J.

Inhal Toxicol. 2007 Jun;19(8):631-43.

PMID:
17510836
19.

Exposure control strategies in the carbonaceous nanomaterial industry.

Dahm MM, Yencken MS, Schubauer-Berigan MK.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S68-73. doi: 10.1097/JOM.0b013e31821b1d3b.

PMID:
21654421
20.

The role of state public health agencies in national efforts to track workplace hazards and the relevance of state experiences to nanomaterial worker surveillance.

Roisman R, Materna B, Beckman S, Katz E, Shusterman D, Harrison R.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S38-41. doi: 10.1097/JOM.0b013e31821ad8bd.

PMID:
21654415

Supplemental Content

Support Center